217 related articles for article (PubMed ID: 16891850)
1. [Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors].
Bonora S; Calcagno A; Gonzalez de Requena D; Bargiacchi O; Di Perri G
Infez Med; 2006 Jun; 14(2):61-70. PubMed ID: 16891850
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside and nucleotide reverse transcriptase inhibitors in children.
Giaquinto C; Rampon O; Penazzato M; Fregonese F; De Rossi A; D'Elia R
Clin Drug Investig; 2007; 27(8):509-31. PubMed ID: 17638393
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside/nucleotide reverse transcriptase inhibitor drug interactions.
Samarasinghe YP; Boffito M; Di Perri G
J HIV Ther; 2004 Nov; 9(4):79-86. PubMed ID: 15731739
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors.
Piliero PJ
J Acquir Immune Defic Syndr; 2004 Sep; 37 Suppl 1():S2-S12. PubMed ID: 15319664
[TBL] [Abstract][Full Text] [Related]
5. The ideal nucleoside/nucleotide backbone.
Gallant JE
J Acquir Immune Defic Syndr; 2004 Sep; 37 Suppl 1():S44-51. PubMed ID: 15319669
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Sharma PL; Nurpeisov V; Hernandez-Santiago B; Beltran T; Schinazi RF
Curr Top Med Chem; 2004; 4(9):895-919. PubMed ID: 15134548
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
8. [Reverse transcriptase inhibitors, protease inhibitors].
Tachikawa N
Nihon Rinsho; 2012 Apr; 70(4):579-95. PubMed ID: 22568138
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.
Cihlar T; Ray AS
Antiviral Res; 2010 Jan; 85(1):39-58. PubMed ID: 19887088
[TBL] [Abstract][Full Text] [Related]
10. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
11. Delavirdine: a review of its use in HIV infection.
Scott LJ; Perry CM
Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019
[TBL] [Abstract][Full Text] [Related]
12. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
Miller V; Larder BA
Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
[TBL] [Abstract][Full Text] [Related]
13. HIV nucleoside reverse transcriptase inhibitors.
Amblard F; Patel D; Michailidis E; Coats SJ; Kasthuri M; Biteau N; Tber Z; Ehteshami M; Schinazi RF
Eur J Med Chem; 2022 Oct; 240():114554. PubMed ID: 35792384
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors.
Weiss J; Weis N; Ketabi-Kiyanvash N; Storch CH; Haefeli WE
Eur J Pharmacol; 2008 Jan; 579(1-3):104-9. PubMed ID: 18037401
[TBL] [Abstract][Full Text] [Related]
15. Essential benefits of nucleoside analogue regimens in failing therapy.
Geretti AM
J HIV Ther; 2004 May; 9(2):28-33. PubMed ID: 15238873
[TBL] [Abstract][Full Text] [Related]
16. New nucleoside/nucleotide backbone options: a review of recent studies.
Ruane PJ; DeJesus E
J Acquir Immune Defic Syndr; 2004 Sep; 37 Suppl 1():S21-9. PubMed ID: 15319666
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV.
Dailly E; Allavena C; Deslandes G; Bouquie R; Jolliet P; Raffi F
Curr Clin Pharmacol; 2014; 9(4):399-403. PubMed ID: 24218996
[TBL] [Abstract][Full Text] [Related]
18. Investigational reverse transcriptase inhibitors for the treatment of HIV.
Cory TJ; Midde NM; Rao P; Kumar S
Expert Opin Investig Drugs; 2015; 24(9):1219-28. PubMed ID: 26088266
[TBL] [Abstract][Full Text] [Related]
19. Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.
Akanbi MO; Scarsi KK; Taiwo B; Murphy RL
Expert Opin Pharmacother; 2012 Jan; 13(1):65-79. PubMed ID: 22149368
[TBL] [Abstract][Full Text] [Related]
20. Understanding the reverse transcriptase inhibitors in HIV.
Edmonds-Ogbuokiri J
Fac Notes (New Orleans La); 1998; 10(6):13-5. PubMed ID: 11366142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
